E2D (p.Glu2Asp) variant of CHAMP1 (Q96JM3)
E2D (p.Glu2Asp) in CHAMP1 (Q96JM3) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.27 / 1. The record also includes structural context.
E2D (p.Glu2Asp) variant details
- p.Glu2Asp
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.266
- ESM-1b 0.00
- AlphaMissense 0.11
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available